Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Midwest BioResearch (MBR) was a specialized contract research organization (CRO) providing bioanalytical and drug development services to the biopharmaceutical industry. Based in Skokie, Illinois, the company focused on large molecule bioanalysis, offering expertise in pharmacokinetic (PK) and toxicokinetic (TK) studies, immunogenicity testing, and cell-based assays. Operating out of a GLP-compliant facility, MBR supported clients through all phases of drug development, from preclinical research to clinical trials. In 2010, the company was acquired by Intertek, a leading total quality assurance provider, to expand its global life sciences division and enhance its bioanalytical capabilities for biologics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Midwest BioResearch.